Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosapride for Recovery of Intestinal Motility After Colorectal Cancer Surgery
NCT04905147Unknown
- Sponsor
- Mahidol University
- Start
- Jul 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of mosapride in postoperative ileus (POI) (2 arms), sponsored by Mahidol University. Primary endpoint: Postoperative time to the first passage of flatus at 72 hours. Status: unknown.
02
Drugs
mosapride
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT04905147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04905147.